The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kirilenko N.P.

Tver State Medical University

Ilina N.N.

Tver State Medical University

COVID-19 and cardiovascular disease: cardiovascular comorbidity, incidence of COVID-19, severity and post-COVID syndrome

Authors:

Kirilenko N.P., Ilina N.N.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(5): 79‑85

Read: 2224 times


To cite this article:

Kirilenko NP, Ilina NN. COVID-19 and cardiovascular disease: cardiovascular comorbidity, incidence of COVID-19, severity and post-COVID syndrome. Russian Journal of Preventive Medicine. 2022;25(5):79‑85. (In Russ.)
https://doi.org/10.17116/profmed20222505179

Recommended articles:
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
«Cytokine storm» as an immu­nopathologic reaction in pregnant women in the first trimester. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):19-24
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146

References:

  1. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report. Accessed March 9, 2022. https://www. who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4
  2. Drapkina OM, Samorodskaya IV, Kakorina EP, Semenov VYu. COVID-19 and regional mortality in the Russian Federation. Profilakticheskaya medicina. 2021;24(7):14-21. (In Russ.). https://doi.org/10.17116/profmed20212407114
  3. Zdravookhraneniye Rossii, 2021. Accessed March 9, 2022. (In Russ.). https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf
  4. Boytsov SA, Pogosova NV, Paleev FN, Ezhov MV, Komarov AL, Pevzner DV, Gruzdev KA, Barinova IV, Suvorov AYu, Alekseeva IA, Mil’ko OV. Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19. Kardiologiia. 2021;61(2):4-14. (In Russ.). https://doi.org/10.18087/cardio.2021.2.n1532
  5. Glybochko PV, Fomin VV, Avdeev SN, Moiseev SV, Yavorovskij AG, Brovko MYu, Umbetova KT, Aliev VA, Bulanova EL, Bondarenko IB, Volkova OS, Gajnitdinova VV, Gneusheva TYu, Dubrovin KV, Kapustina VA, Kraeva VV, Merzhoeva ZM, Nuralieva GS, Nogtev PV, Panasyuk VV, Politov ME, Popov AM, Popova EN, Raspopina NA, Royuk VV, Sorokin YuD, Trushenko NV, Halikova EYu, Careva NA, Chikina SYu, Chichkova NV, Akulkina LA, Bulanov NM, Ermolova LA, Zykova AS, Kitbalyan AA, Moiseev AS, Potapov PP, Tao EA, Sholomova VI, Shchepalina AA, Yakovleva AA. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Klinicheskaya farmakologiya i terapiya. 2020;29(2):21-29. (In Russ.). https://doi.org/10.32756/0869-5490-2020-2-21-29
  6. Epidemiologicheskij slovar’. Pod red. D.M. Lasta. Dlya Mezhdunarodnoj epidemiologicheskoj associacii. M. 2009. Accessed March 9, 2022. (In Russ.). https://osdm.org/wp-content/uploads/2014/05/epid_dict.pdf
  7. Kirilenko NP, Koroleva OM, Krasnenkov VL, Solov’eva AV, Zhmakin IA, Kalinkin MN. Mobile health care in the Tver region: from idea to implementation and promotion. Profilakticheskaya medicina. 2019;22(3):44-50. (In Russ.). https://doi.org/10.17116/profmed20192203144
  8. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2020;94:91-95.  https://doi.org/10.1016/j.ijid.2020.03.017
  9. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020;109(5):531-538.  https://doi.org/10.1007/s00392-020-01626-9
  10. Böger B, Fachi M, Vilhena R, Cobre A, Tonin F, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. American Journal of Infection Control. 2021;49(1):21-29.  https://doi.org/10.1016/j.ajic.2020.07.011
  11. Sugraliyev AB. Cardiac Involvement in COVID-19. Kardiologiia. 2021;61(4): 15-23. (In Russ.). https://doi.org/10.18087/cardio.2021.4.n1408
  12. Bean DM, Kraljevic Z, Searle T, Bendayan R, Kevin O, Pickles A, Folarin A, Roguski L, Noor K, Shek A, Zakeri R, Shah AM, Teo JTH, Dobson RJB. Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust. European Journal of Heart Failure. 2020;22(6):967-974.  https://doi.org/10.1002/ejhf.1924
  13. Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, He Q, Wang Z, Liu Y, Liu L, Chen J, Xu L. Obesity and CO-VID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392-1398. https://doi.org/10.2337/dc20-0576
  14. Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, Kario K, Kishi T, Mogi M, Nishiyama A, Ohishi M, Ohkubo T, Tamura K, Tanaka M, Yamamoto E, Yamamoto K, Itoh H. Hypertension and related diseases in the era of COVID-19: areport from the Japanese Society of Hypertension Task Force on COVID-19. Hypertension Research. 2020;43(10): 1028-1046. https://doi.org/10.1038/s41440-020-0515-0
  15. Centers for Disease Control and Prevention. People at Increased Risk for Severe Illness. 2020. Accessed March 9, 2022. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/index.html
  16. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems during the Coronavirus Disease 2019 (COVID-19) Pandemic. Journal of the American College of Cardiology. 2020;75(18):2352-2371. https://doi.org/10.1016/j.jacc.2020.03.031
  17. Tai S, Tang J, Yu B, Tang L, Wang Y, Zhang H, Zhu W, Xiao K, Wen C, Tan C, Jiang Z, Jiang C, Zhu L, Jiang L, Liu Q, Hu X, Fang Z, Li X, Sun J, Zhu Z, Yang H, Tu T, Xiao Y, Chen M, He Y, Chai X, Xu J, Zhou S. Association between cardiovascular burden and requirement of intensive care among patients with mild COVID-19. Cardiovascular Therapeutics. 2020; 2020:9059562. https://doi.org/10.1155/2020/9059562
  18. Ivannikov A.A., Esaulenko A.N., Vasilchenko M.K., Alidzhanova KG, Petrikov SS. COVID-19 and the cardiovascular system. Part II. Bridge syndrome. N.V. Zhurnal im. N.V. Sklifosovskogo «Neotlozhnaya medicinskaya pomoshch». 2021;10(2):248-258. (In Russ.). https://doi.org/10.23934/2223-9022-2021-10-2-248-258
  19. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, González-delaAleja P, Boix V, Gil J; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. The Journal of Infection. 2021;82(3):378-383.  https://doi.org/10.1016/j.jinf.2021.01.004
  20. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A Review of Persistent Post-COVID Syndrome (PPCS). Clinical Reviews in Allergy and Immunology. 2021;1-9. Online ahead of print. Accessed March 9, 2022. https://doi.org/10.1007/s12016-021-08848-3
  21. Carfì A, Bernabei R, Landi F; Gemelli against COVID-19 Post-Acute Care Study Group. Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute Covid-19. JAMA. 2020;324(6):603-605.  https://doi.org/10.1001/jama.2020.12603
  22. Willi S, Lüthold R, Hunt A, Hänggi NV, Sejdiu D, Scaff C, Bender N, Staub K, Schlagenhauf P. COVID-19 Sequelae in adults aged less than 50 years: A Systematic Review. Travel Medicine and Infectious Disease. 2021; 40:101995. https://doi.org/10.1016/j.tmaid.2021.101995
  23. Iqbal A, Iqbal K, Arshad Ali S, Azim D, Farid E, Baig MD, Bin Arif T, Raza M. The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors. Cureus. 2021;13(2):e13080. https://doi.org/10.7759/cureus.13080
  24. Bermejo-Martin JF, Almansa R, Torres A, González-Rivera M, Kelvin DJ. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Cardiovascular Research. 2020;116(10):e132-e133. https://doi.org/10.1093/cvr/cvaa140
  25. Simmonds P, Williams S, Harvala H. Understanding the outcomes of COVID-19—does the current model of an acute respiratory infection really fit? The Journal of General Virology. 2021;102(3):001545. https://doi.org/10.1099/jgv.0.001545
  26. Poredos P, Jezovnik MK. Endothelial dysfunction and venous thrombosis. Angiology. 2018;69(7):564-567.  https://doi.org/10.1177/0003319717732238
  27. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. The New England Journal of Medicine. 2020;383(2): 120-128.  https://doi.org/10.15829/1560-4071-2020-3-3801

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.